Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Cancer patients are at high risk for potential drug interactions
May 2nd, 2007
Potential drug interactions from prescribed medications are common among cancer patients and may cause unnecessary harm, according to a study in the Journal of the National Cancer Institute. Cancer patients often take several medications at the same time, not only for treating their cancer but also for side effects and other secondary illnesses. Because of this, they can be at high risk for adverse drug interactions and duplicate medications. Consequences of these interactions can range from inactivation of cancer-fighting medications to severely injuring or killing the patient. Rachel Riechelmann, M.D., of the Princess Margaret Hospital in Toronto,...
Source: Biotech Week (2007-05-02)
|
